Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle

Journal of Cellular Physiology

Volumn 203, Issue 1, 2005, Pages 144-155

  Lang, Charles H ^a   Frost, Robert A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GLUCOCORTICOID RECEPTOR ANTAGONIST; INITIATION FACTOR 1; INITIATION FACTOR 4E BINDING PROTEIN 1; LEUCINE; LIPOPOLYSACCHARIDE; MAMMALIAN TARGET OF RAPAMYCIN; MIFEPRISTONE; SOMATOMEDIN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; GASTROCNEMIUS MUSCLE; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSLATION INITIATION; WESTERN BLOTTING;

ANIMALS; CARRIER PROTEINS; GLUCOCORTICOIDS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEUCINE; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SKELETAL; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA;

EID: 14744267948     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20207     Document Type: Article

References (56)

1. Anthony JC, Anthony TG, Layman DK. 1999. Leucine supplementation enhances skeletal muscle recovery in rats following exercise. J Nutr 129:1102-1106.
2. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, LS, Jefferson SR. 2000. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 130:2413-2419.
3. Anthony JC, Lang CH, Crozier SJ, Anthony TG, MacLean DA, Kimball SR, Jefferson LS. 2002. Contribution of insulin to the translational control of protein synthesis in skeletal muscle by leucine. Am J Physiol Endocrinol Metab 282:E1092-E1101.
4. Bark TH, McNurlan MA, Lang CH, Garlick PJ. 1998. Increased protein synthesis after acute IGF-I or insulin infusion is localized to muscle in mice. Am J Physiol Endocrinol Metab 275:E180-E193.
5. Buse MG, Reid SS. 1975. Leucine: A possible regulator of protein turnover in muscle. J Clin Invest 56:1250-1261.
6. Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Chenge JQ. 2002. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 277:35364-35370.
7. Dufner A, Thomas G. 1999. Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 253:100-109.
8. Duncan R, Milburn SC, Hershey JW. 1987. Regulated phosphorylation and low abundance of HeLa cell initiation factor 4F suggest a role in translational control. Heat shock effect on eIF-4F. J Biol Chem 262:380-388.
9. Fan J, Molina PE, Gelato MC, Lang CH. 1994. Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134:1685-1692.
10. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J. 2004. mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24:200-216.
11. Fox HL, Kimball SR, Jefferson LS, Lynch CJ. 1998. Amino acids stimulate phosphorylation of p70 S6 kinase and organization of rat adipocytes into multicellular clusters. Am J Physiol Cell Physiol 274:C206-C213.
12. Gao X, Zhang Y, Arrazola P, Hino O, Kobayaski T, Yeung RS, Ru B, Pan D. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat Cell Biol 4:699-704.
13. Gautsch TA, Anthony JC, Kimball SR, Paul GL, Layman DK, Jefferson LS. 1998. Availability of eIF4E regulates skeletal muscle protein synthesis during recovery from exercise. Am J Physiol Cell Physiol 274:C406-C414.
14. Gingras A-C, Raught B, Gygi SP, Niedzwiecka A, Miron M, Burley SK, Polakiewicz RD, Wyslouch-Cieszynska A, Aebersold R, Sonenberg N. 2001a. Hierarchical phosphorylation of the translational inhibitor 4E-BP1 Genes Dev 15:2852-2864.
15. Gingras A-C, Raught B, Sonenberg N. 2001b. Regulation of translation initiation by FRAP/TOR. Genes Dev 15:807-826.
16. Hallemeesch MM, Cobben DCP, Dejong CHC, Soeters PB, Deutz NEP. 2000. Renal amino acid metabolism during endotoxemia in the rat. J Surg Res 92:193-200.
17. Hara K, Yonezawa K, Kozlowski MT, Sugimoto T, Andrabi K, Weng QP, Kasuga M, Nishimoto I, Avruch J. 1997. Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem 272:26457-26463.
18. Hara K, Kazuyoshi K, Weng Q-P, Kozlowski MT, Belha G, Avruch J. 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J Biol Chem 273:14484-14494.
19. Hobler SC, Williams AB, Fischer JE, Hasselgren P-O. 1998. IGF-I stimulates protein synthesis but does not inhibit protein breakdown in muscle from septic rats. Am J Physiol Regul Integr Comp Physiol 274:R571-R576.
20. Iiboshi Y, Papst PJ, Kawasome H, Hosoi H, Abraham RT, Houghton PJ, Terada N. 1999. Amino acid-dependent control of p70S6K. Involvement of tRNA aminoacylation in the regulation. J Biol Chem 274:1092-1099.
21. Inoki K, Li Y, Zhu T, Wu J, Guan KL. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nat Cell Biol 4:648-657.
22. Jurasinski CV, Vary TC. 1995. Insulin-like growth factor I accelerates protein synthesis in skeletal muscle during sepsis. Am J Physiol Endocrinol Metab E977-E981.
23. Jurasinski C, Gray K, Vary TC. 1995. Modulation of skeletal muscle protein synthesis by amino acids and insulin during sepsis. Metabolism 44:1130-1138.
24. Kimball SR, Shantz LM, Horetsky RL, Jefferson LS. 1999. Leucine regulates translation of specific mRNAs in L6 myoblasts through mTOR-mediated changes in availability of eIF4E and phosphorylation of ribosomal-protein S6. J Biol Chem 274:11647-11652.
25. Kimball SR, Orellana RA, O'Connor PMJ, Suryawan A, Bush JA, Nguyen HV, Thivierge MC, Jefferson LS, Davis TA. 2003. Endotoxin induces differential regulation of mTOR-dependent signaling in skeletal muscle and liver of neonatal pigs. Am J Physiol Endocrinol Metab 285:E637-E644.
26. Kumar V, Frost RA, Lang CH. 2002. Alcohol impairs insulin and IGF-I stimulation of S6K1 but not 4E-BP1 in skeletal muscle. Am J Physiol Endocrinol Metab 283:E917-E928.
27. Lang CH, Frost RA, Jefferson LS, Kimball SR, Vary TC. 2000. Endotoxin-induced decrease in muscle protein synthesis is associated with changes in eIF2B, eIF4E, and IGF-I. Am J Physiol Endocrinol Metab 278:E1133-E1143.
28. Lang CH, Nystrom GJ, Frost RA. 2001. Burn-induced changes in IGF-I and IGF-binding proteins are partially glucocorticoid dependent. Am J Physiol Regul Integr Comp Physiol 282:R207-R215.
29. Lang CH, Frost RA, Nairn AC, MacLean DA, Vary TC. 2002. TNFα impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 282:E336-E347.
30. Lang CH, Frost RA, Deshpande N, Kumar V, Jefferson LS, Kimball SR. 2003a. Alcohol impairs leucine-mediated phosphorylation of 4E-BP1, S6K1, eIF4G, and mTOR in skeletal muscle. Am J Physiol Endocrinol Metabol 285:E1205-E1215.
31. Lang CH, Vary TC, Frost RA. 2003b. Acute in vivo elevation in IGFBP-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 144:3922-3933.
32. Li JB, Jefferson LS. 1978. Influence of amino acid availability on protein turnover in perfused skeletal muscle. Biochim Biophys Acta 544:351-359.
33. Li YH, Fan J, Lang CH. 1997. Differential role of glucocorticoids in mediating endotoxin-induced changes in IGF-I and IGFBP-1. Am J Physiol Regul Integr Comp Physiol 272:R1990-R1997.
34. Lynch CJ. 2001. Role of leucine in the regulation of mTOR by amino acids: Revelations from structure-activity studies. J Nutr 131:8618-8658.
35. Lynch CJ, Patson BJ, Anthony J, Vaval A, Jefferson LS, Vary TC. 2002. Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue. Am J Physiol Endocrinol Metab 283:E503-E513.
36. Mao J, Regelson W, Kalimi M. 1992. Molecular mechanism of RU486 action: A review. Mol Cell Biochem 109:1-8.
37. Martin-Perez J, Thomas G. 1983. Ordered phosphorylation of 408 ribosomal protein S6 after serum stimulation of quiescent 3T3 cells. Proc Natl Acad Sci USA 80:926-930.
38. May ME, Buse MG. 1989. Effects of branched-chain amino acids on protein turnover. Diabetes Metab Rev 5:227-245.
39. Orellana RA, O'Connor PMJ, Nguyen HV, Bush JA, Suryawan A, Thivierge MC, Fiorotto ML, Davis TA. 2002. Endotoxemia reduces skeletal muscle protein synthesis in neonates. Am J Physiol Endocrinol Metab 283:E909-E916.
40. Pain VM. 1997. Initiation of protein synthesis in eukaryotic cells. Eur J Biochem 236:747-717.
41. Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC, Thomas G. 2004. S6K1-/-/S6K2-/- mice exhibit perinatal lethality and rapamycin-sensitive 5′-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway. Mol Cell Biol 24:3112-3124.
42. Richardson CJ, Schalm SS, Blenis J. 2004. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol 15:147-159.
43. Shah OJ, Anthony JC, Kimball SR, Jefferson LS. 2000a. 4E-BP1 and S6K1: Translational integration sites for nutritional and hormonal information in muscle. Am J Physiol Endocrinol Metab 279:E715-E729.
44. Shah OJ, Anthony JC, Kimball SR, Jefferson LS. 2000b. Glucocorticoids oppose translational control by leucine in skeletal muscle. Am J Physiol Endocrinol Metab 279:E1185-E1190.
45. Shah OJ, Kimball SR, Jefferson LS. 2000c. Among translational effectors, p70S6K is uniquely sensitive to inhibition by glucocorticoids. Biochem J 347:389-397.
46. Stolovich M, Tang H, Hornstein E, Levy G, Cohen R, Bae SS, Birnbaum MJ, Meyuhas O. 2002. Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation. Mol Cell Biol 22:8101-8113.
47. Svanberg E, Moller A-C, Mathews DE, Korner U, Anderson M, Lundholm K. 1996. Effects of amino acids on synthesis and degradation of skeletal muscle proteins in humans. Am J Physiol Endocrinol Metab 271:E718-E724.
48. Tang H, Hornstein E, Stolovich M, Levy G, Livingstone M, Templeton D, Avruch J, Meyuhas O. 2001. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol 21:8671-8683.
49. Tee AR, Fingar DC, Manning BD, Kwiatkowski DJ, Cantley LC, Blenis J. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc Natl Acad Sci USA 99:648-657.
50. van Sluijters DA, Dubbelhuis PF, Blommaart FC, Meijer AJ. 2000. Amino-acid-dependent signal transduction. Biochem J 351:545-550.
51. Vary TC, Kimball SR. 1992. Sepsis-induced changes in protein synthesis: Differential effects on fast- and slow-twitch muscles. Am J Physiol Cell Physiol 262:C1513-C1519.
52. Vary TC, Kimball SR. 2000. Effect of sepsis on eIF4E availability in skeletal muscle. Am J Physiol Endocrinol Metab 279:E1178-E1184.
53. Vary TC, Dardevet D, Grizard J, Voisin L, Buffiere C, Denis P, Breuille D, Obled C. 1998. Differential regulation of skeletal muscle protein turnover by insulin and IGF-I after bacteremia. Am J Physiol Endocrinol Metab 275:E584-E593.
54. Vary TC, Jefferson LS, Kimball SR. 1999. Amino acid-induced stimulation of translation initiation in rat skeletal muscle. Am J Physiol Endocrinol Metab 277:E1077-E1086.
55. Weng QP, Kozlowski M, Belham C, Zhang A, Comb MJ, Avruch J. 1998. Regulation of the p70 S6 kinase by phosphorylation in vivo. Analysis using site-specific anti-phosphopeptide antibodies. J Biol Chem 273:16621-16629.
56. Zamir O, Hasselgren P-O, von Allmen D, Fischer JE. 1991. The effect of interleukin-1 and the glucocorticoid receptor blocker RU38486 on total and myofibrillar protein breakdown in skeletal muscle. J Surg Res 50:570-583.